Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
Journal of Internal Medicine|December 3, 2003
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic menJ Skogsberg, A D McMahon, F Karpe, et al.
International Journal of Molecular Medicine|June 14, 2000
Characterization of the human peroxisome proliferator activated receptor delta gene and its expressionJ Skogsberg, K Kannisto, L Roshani, et al.
Annals of Medicine|October 1, 1992
DNA polymorphism studies. Approaches to elucidating multifactorial ischaemic heart disease: the apo B gene as an exampleS E Humphries, A Dunning, C F Xu, et al.
Journal of Lipid Research|February 13, 2001
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglyceridesF Karpe, S Boquist, R Tang, et al.
Diabetes|June 26, 2001
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathwayC Banfi, P Eriksson, G Giandomenico, et al.
British Heart Journal|August 1, 1995
Long-term prognostic significance of M mode echocardiography in young men after myocardial infarctionS V Eriksson, K Caidahl, A Hamsten, et al.
The Journal of Biological Chemistry|May 31, 1996
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expressionS Ye, P Eriksson, A Hamsten, et al.
Lancet (London, England)|March 30, 1996
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patientsC G Ericsson, A Hamsten, J Nilsson, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trialsU de Faire, C G Ericsson, L Grip, et al.
The Journal of Biological Chemistry|May 25, 1993
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cellsS J Dawson, B Wiman, A Hamsten, et al.
Pageof 26